Skip to content
Back to Investors
British Business Bank

British Business Bank

Government

The British Business Bank is a government-owned financial institution operating economic development initiatives and investment programmes for smaller businesses.


Recent investments

Pre-Seed
£585K

Haatch led the pre-seed round with backing from the East Midlands Combined Authority and the British Business Bank.

"Our platform enables people in the business to onboard AI Teammates where work happens, whilst real-time guardrails and audit logs protect and govern. Customers gain AI productivity at speed, with regulatory-compliant trust."
— Mark Wood
Pre-Seed
£585K

Haatch led the pre-seed round, which includes contributions from the British Business Bank and the East Midlands Combined County Authority.

"As a trusted advisor to financial services boards, I kept seeing the same pattern: teams got excited about the potential of generative AI but then hit a wall when asked about governance and compliance. We founded Vigilant AI.ai because the toolset to answer those questions simply didn’t exist. Our platform enables people in the business to onboard AI Teammates where work happens whilst real-time guardrails and audit logs protect and govern. Customers gain AI productivity at speed, with regulatory compliant trust."
— Mark Wood, Co-founder and CTO
Series B
£50.0M

The financing round was led by SV Health Investors and will fund initial human trials for the company lead candidate in ALS and Parkinson's.

"Developing new drugs to treat neurological diseases is very challenging, but is receiving increased interest given the high unmet medical need and growing prevalence in ageing populations."
— Neil Miller, CEO
Series B
£33.0M

The financing round was led by EQT Life Sciences alongside co-leads Advent Life Sciences and British Business Bank.

"This Series B financing marks a defining moment for Cyted as we continue to deepen our commitment to detecting esophageal diseases earlier. This investment will help us consolidate our leading position in the market by expanding our US presence and adding new life-saving innovations to our advanced diagnostics portfolio."
— Marcel Gehrung, CEO and Co-founder